| Descriptor English: | Sarcoma, Kaposi | ||||
| Descriptor Spanish: |
Sarcoma de Kaposi
| ||||
| Descriptor Portuguese: | Sarcoma de Kaposi | ||||
| Descriptor French: | Sarcome de Kaposi | ||||
| Entry term(s): |
Kaposi Sarcoma Kaposi's Sarcoma Kaposis Sarcoma Multiple Idiopathic Pigmented Hemangiosarcoma Sarcoma, Kaposi's |
||||
| Tree number(s): |
C01.925.256.466.860 C04.557.450.795.850 C04.557.645.750 |
||||
| RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D012514 | ||||
| Scope note: | A multicentric, malignant neoplastic vascular proliferation characterized by the development of bluish-red cutaneous nodules, usually on the lower extremities, most often on the toes or feet, and slowly increasing in size and number and spreading to more proximal areas. The tumors have endothelium-lined channels and vascular spaces admixed with variably sized aggregates of spindle-shaped cells, and often remain confined to the skin and subcutaneous tissue, but widespread visceral involvement may occur. Kaposi's sarcoma occurs spontaneously in Jewish and Italian males in Europe and the United States. An aggressive variant in young children is endemic in some areas of Africa. A third form occurs in about 0.04% of kidney transplant patients. There is also a high incidence in AIDS patients. (From Dorland, 27th ed & Holland et al., Cancer Medicine, 3d ed, pp2105-7) HHV-8 is the suspected cause. |
||||
| Annotation: | coordinate IM with precoordinated organ/ neoplasm term (IM) |
||||
| Allowable Qualifiers: |
BL blood BS blood supply CF cerebrospinal fluid CH chemistry CI chemically induced CL classification CN congenital CO complications DG diagnostic imaging DH diet therapy DI diagnosis DT drug therapy EC economics EH ethnology EM embryology EN enzymology EP epidemiology ET etiology GE genetics HI history IM immunology ME metabolism MI microbiology MO mortality NU nursing PA pathology PC prevention & control PP physiopathology PS parasitology PX psychology RH rehabilitation RT radiotherapy SC secondary SU surgery TH therapy UL ultrastructure UR urine VE veterinary VI virology |
||||
| Public MeSH Note: | 98; was SARCOMA, KAPOSI'S 1963-97; KAPOSI SARCOMA was KAPOSI'S SARCOMA 1963-97 |
||||
| History Note: | 98; was SARCOMA, KAPOSI'S 1963-97; KAPOSI SARCOMA was KAPOSI'S SARCOMA 1963-97 |
||||
| DeCS ID: | 12893 | ||||
| Unique ID: | D012514 | ||||
| Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||
| Date Established: | 1998/01/01 | ||||
| Date of Entry: | 1999/01/01 | ||||
| Revision Date: | 2012/07/03 |
-
-
DISEASES
Infections [C01]Infections -
DISEASES
Neoplasms [C04]Neoplasms -
DISEASES
Neoplasms [C04]Neoplasms
|
|
Sarcoma, Kaposi
- Preferred
| Concept UI |
M0019437 |
| Scope note | A multicentric, malignant neoplastic vascular proliferation characterized by the development of bluish-red cutaneous nodules, usually on the lower extremities, most often on the toes or feet, and slowly increasing in size and number and spreading to more proximal areas. The tumors have endothelium-lined channels and vascular spaces admixed with variably sized aggregates of spindle-shaped cells, and often remain confined to the skin and subcutaneous tissue, but widespread visceral involvement may occur. Kaposi's sarcoma occurs spontaneously in Jewish and Italian males in Europe and the United States. An aggressive variant in young children is endemic in some areas of Africa. A third form occurs in about 0.04% of kidney transplant patients. There is also a high incidence in AIDS patients. (From Dorland, 27th ed & Holland et al., Cancer Medicine, 3d ed, pp2105-7) HHV-8 is the suspected cause. |
| Preferred term | Sarcoma, Kaposi |
| Entry term(s) |
Kaposi Sarcoma Kaposi's Sarcoma Kaposis Sarcoma Multiple Idiopathic Pigmented Hemangiosarcoma Sarcoma, Kaposi's |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey
